FDA Warning Letter — BP

Case 581701 — FEI 3011724757

The FDA took a Warning Letter action against BP on May 9, 2019 (New Brunswick, NJ). The action was issued by CTP and concerns tobacco products.

Action details

Facility
BP
Date
May 9, 2019
Fiscal Year
2019
Product Type
Tobacco
Center
CTP
Location
New Brunswick, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.